Global Market Study on Antibiotic Resistance: Approval & Launch of Novel Therapeutics Aiding Market Expansion

Global Market Study on Antibiotic Resistance: Approval & Launch of Novel Therapeutics Aiding Market Expansion

  • Persistence Market Research
  • February 2021
  • Healthcare
  • 272 pages

Report Description

Antibiotic Resistance Market - Scope of Report

A latest publication by Persistence Market Research on the global antibiotic resistance market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the antibiotic resistance market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.

Important indicators for the successful growth of the antibiotic resistance market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market and compounded annual growth rate (CAGR), which are described in an exhaustive way in Persistence Market Research's study. This research study can support readers know the demand for antibiotic resistance products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the antibiotic resistance space, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the market. Insights and wisdom presented in this Persistence Market Research study can be leveraged by shareholders in the antibiotic resistance market, industry experts, investors, researchers, reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the antibiotic resistance market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the antibiotic resistance industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the antibiotic resistance market offers information divided into six important segments — drug class, pathogen, disease, mechanism of action, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics, and growth parameters associated with these categories.

Drug Class

  • Beta Lactam Antibiotics
  • Cephalosporin
  • Quinolones Antibiotics
  • Macrolide Antibiotics
  • Tetracycline
  • Oxazolidinones
  • Others

Pathogen

  • Staphylococcus aureus
  • Streptococcus pneumonia
  • Neisseria gonorrhoeae
  • Enterococcus faecium
  • Escherichia coli
  • Klebsiella Pneumonia
  • Shigella
  • Clostridium difficile
  • Others

Disease

  • Community Acquired Bacterial Pneumonia (CABP)
  • Hospital Acquired Bacterial Pneumonia/ Ventilator (HABP/VABP)
  • Complicated Urinary Tract Infections (CUTI)
  • Complicated Intra-Abdominal Infections (CIAI)
  • Blood Stream Infections (BSI)
  • Abdominal Infection and Diarrhoea (Clostridium difficile infections (CDI) & Shigella)
  • Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
  • Drug Resistant Gonorrhoeae

Mechanism of Action

  • Cell Wall Synthesis Inhibitors
  • Protein Synthesis Inhibitors
  • DNA Synthesis Inhibitors
  • RNA Synthesis Inhibitors
  • Others

Distribution Channel

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • MEA

Key Questions Answered in Report

  • Which regions will continue to remain the most profitable markets for antibiotic resistance?
  • Which parameters will bring a change in the demand for antibiotic resistance products during the forecast period?
  • How will changing trends impact the market?
  • How will the COVID-19 pandemic impact market growth?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the winning strategies of stakeholders in the antibiotic resistance market to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and might tackle while investing in the market?
  • How can businesses in the antibiotic resistance market avail the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the antibiotic resistance market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the antibiotic resistance market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the antibiotic resistance market more accurate and reliable.

Keywords

  • Antibiotic Resistance Market, Size
  • Share
  • Demand
  • Growth
  • Analysis
  • Research Report
  • Antibiotic Resistance Testing Market
  • Antimicrobial Resistance
  • Infection Prevention Devices Market
  • Healthcare
  • Pharmaceutical
  • Infection Prevention
  • Disease Prevention

Countries Covered

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • MEA

Have query on this report?

Make an Enquiry

Table of Content

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion & Exclusion/ Scope of the Report

3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Development Trends

4. Key Success Factors
4.1. Disease Epidemiology
4.2. Key Regulation Scenario
4.3. Pipeline Analysis
4.4. Treatment Regime (Prescription Pattern)
4.5. Reimbursement Scenario

5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Per Capita Healthcare Expenditure Outlook
5.1.3. Regional Healthcare Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. Product Availability
5.2.3. Product Adoption
5.2.4. Procedure Cost
5.2.5. Increasing Case of Toxicology and New Product Launches
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
5.4. Value Chain Analysis 

6. COVID19 Crisis Analysis
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 financial analysis
6.4. COVID19 and Impact Analysis
6.4.1. Revenue By Drug Class 
6.4.2. Revenue By Pathogen
6.4.3. Revenue By Disease
6.4.4. Revenue By Mechanism of action
6.4.5. Revenue By Distribution Channel
6.4.6. Revenue By Region
6.5. 2020 Market Scenario
6.6. Quarter by Quarter Forecast
6.7. Projected recovery Quarter

7. Global Antibiotic Resistance Market Volume (Mn Units) Analysis 2016-2020 and Forecast, 2021-2031
7.1. Historical Market Volume (Mn- Units) Analysis, 2016-2020
7.2. Current and Future Market Volume (Mn- Units) Projections, 2021-2031
7.2.1. Y-o-Y Growth Trend Analysis

8. Global Antibiotic Resistance Market - Pricing Analysis
8.1. Regional Pricing Analysis By Device Type
8.2. Global Average Pricing Analysis Benchmark

9. Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Opportunity Analysis, 2021-2031

10. Global Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031, By Drug Class 
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume (Mn Units) By Drug Class, 2016-2020
10.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Drug Class, 2021-2031
10.3.1. Beta Lactam Antibiotic
10.3.2. Cephalosporin
10.3.3. Quinolones Antibiotic
10.3.4. Macrolide Antibiotic
10.3.5. Tetracycline
10.3.6. Oxazolidinones
10.3.7. Others
10.4. Market Attractiveness Analysis By Drug Class 

11. Global Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031, By Pathogen 
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Pathogen, 2016-2020
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Pathogen, 2021-2031
11.3.1. Staphylococcus aureus
11.3.2. Streptococcus pneumonia
11.3.3. Neisseria gonorrhoeae
11.3.4. Enterococcus faecium
11.3.5. Escherichia coli
11.3.6. Klebsiella Pneumonia
11.3.7. Shigella
11.3.8. Clostridium difficile
11.3.9. Others
11.4. Market Attractiveness Analysis By Pathogen 

12. Global Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031, By Disease
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By Disease, 2016-2020
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease, 2021-2031
12.3.1. Community Acquired Bacterial Pneumonia (CABP)
12.3.2. Hospitals Acquired Bacterial Pneumonia/ Ventilator (HABP/VABP)
12.3.3. Complicated Urinary Tract Infections (CUTI)
12.3.4. Complicated Intra-Abdominal Infections (CIAI)
12.3.5. Blood Stream Infections (BSI)
12.3.6. Abdominal Infection and Diarrhoea (Clostridium difficile infections (CDI) & Shigella)
12.3.7. Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
12.3.8. Drug Resistant Gonorrhoeae
12.4. Market Attractiveness Analysis By Disease

13. Global Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031, By Mechanism of Action
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) Analysis By Mechanism of Action, 2016-2020
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Mechanism of Action, 2021-2031
13.3.1. Cell Wall Synthesis Inhibitors
13.3.2. Protein Synthesis Inhibitors
13.3.3. DNA Synthesis Inhibitors
13.3.4. RNA Synthesis Inhibitors
13.3.5. Others
13.4. Market Attractiveness Analysis By Disease

14. Global Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2016-2020
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2021-2031
14.3.1. Hospitals Pharmacies
14.3.2. Retail Pharmacies
14.3.3. Online Pharmacies
14.4. Market Attractiveness Analysis By Distribution Channel

15. Global Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031, By Region
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Analysis By Region, 2016-2020
15.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Region, 2021-2031
15.3.1. North America
15.3.2. Latin America
15.3.3. East Asia
15.3.4. South Asia
15.3.5. Oceania
15.3.6. Middle East & Africa
15.4. Market Attractiveness Analysis By Region

16. North America Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume (Mn Units)  Analysis By Market Taxonomy, 2016-2020
16.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Region, 2021-2031
16.3.1. By Country
16.3.1.1. U.S.
16.3.1.2. Canada
16.3.2. By Drug Class
16.3.3. By Pathogen
16.3.4. By Disease
16.3.5. By Mechanism of action
16.3.6. By Distribution Channel
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis

17. Latin America Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume (Mn Units)  Analysis By Market Taxonomy, 2016-2020
17.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Region, 2021-2031
17.3.1.  By Country
17.3.1.1. Brazil
17.3.1.2. Mexico
17.3.1.3. Argentina
17.3.1.4. Rest of Latin America
17.3.2. By Drug Class
17.3.3. By Pathogen
17.3.4. By Disease
17.3.5. By Mechanism of action
17.3.6. By Distribution Channel
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis

18. Europe Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume (Mn Units)  Analysis By Market Taxonomy, 2016-2020
18.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Region, 2021-2031
18.3.1. By Country
18.3.1.1. Germany
18.3.1.2. Italy
18.3.1.3. France
18.3.1.4. U.K.
18.3.1.5. Spain
18.3.1.6. BENELUX
18.3.1.7. Russia
18.3.1.8. Rest of Europe
18.3.2. By Drug Class
18.3.3. By Pathogen
18.3.4. By Disease
18.3.5. By Mechanism of action
18.3.6. By Distribution Channel
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis

19. East Asia Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031
19.1. Introduction
19.2. Historical Market Size (US$ Mn) and Volume (Mn Units)  Analysis By Market Taxonomy, 2016-2020
19.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Region, 2021-2031
19.3.1. By Country
19.3.1.1. China
19.3.1.2. Japan
19.3.1.3. South Korea
19.3.2. By Drug Class
19.3.3. By Pathogen
19.3.4. By Disease
19.3.5. By Mechanism of action
19.3.6. By Distribution Channel
19.4. Market Attractiveness Analysis
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis

20. South Asia Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031
20.1. Introduction
20.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Analysis By Market Taxonomy, 2016-2020
20.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Region, 2021-2031
20.3.1. By Country
20.3.1.1. India
20.3.1.2. Thailand
20.3.1.3. Indonesia
20.3.1.4. Malaysia
20.3.1.5. Rest of South Asia
20.3.2. By Drug Class
20.3.3. By Pathogen
20.3.4. By Disease
20.3.5. By Mechanism of action
20.3.6. By Distribution Channel
20.4. Market Attractiveness Analysis
20.5. Key Market Participants - Intensity Mapping
20.6. Drivers and Restraints - Impact Analysis

21. Oceania Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031
21.1. Introduction
21.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Analysis By Market Taxonomy, 2016-2020
21.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units) Analysis and Forecast By Region, 2021-2031
21.3.1. By Country
21.3.1.1. Australia
21.3.1.2. New Zealand
21.3.2. By Drug Class
21.3.3. By Pathogen
21.3.4. By Disease
21.3.5. By Mechanism of action
21.3.6. By Distribution Channel
21.4. Market Attractiveness Analysis
21.5. Key Market Participants - Intensity Mapping
21.6. Drivers and Restraints - Impact Analysis

22. Middle East and Africa Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031
22.1. Introduction
22.2. Historical Market Size (US$ Mn) and Volume (Mn Units)  Analysis By Market Taxonomy, 2016-2020
22.3. Current and Future Market Size (US$ Mn) and Volume (Mn Units)  Analysis and Forecast By Region, 2021-2031
22.3.1. By Country
22.3.1.1. GCC Countries
22.3.1.2. Turkey
22.3.1.3. South Africa
22.3.1.4. Rest of Middle East and Africa
22.3.2. By Drug Class
22.3.3. By Pathogen
22.3.4. By Disease
22.3.5. By Mechanism of action
22.3.6. By Distribution Channel
22.4. Market Attractiveness Analysis
22.5. Key Market Participants - Intensity Mapping
22.6. Drivers and Restraints - Impact Analysis

23. Key and Emerging Countries Antibiotic Resistance Market Analysis 2016-2020 and Forecast 2021-2031
23.1. Introduction
23.1.1. Market Value Proportion Analysis, By Key Countries
23.1.2. Global Vs. Country Growth Comparison
23.2. U.S. Antibiotic Resistance Market Analysis
23.2.1. By Drug Class
23.2.2. By Pathogen
23.2.3. By Disease
23.2.4. By Mechanism of action
23.2.5. By Distribution Channel
23.3. Canada Antibiotic Resistance Market Analysis
23.3.1. By Drug Class
23.3.2. By Pathogen
23.3.3. By Disease
23.3.4. By Mechanism of action
23.3.5. By Distribution Channel
23.4. Mexico Antibiotic Resistance Market Analysis
23.4.1. By Drug Class
23.4.2. By Pathogen
23.4.3. By Disease
23.4.4. By Mechanism of action
23.4.5. By Distribution Channel
23.5. Brazil Antibiotic Resistance Market Analysis
23.5.1. By Drug Class
23.5.2. By Pathogen
23.5.3. By Disease
23.5.4. By Mechanism of action
23.5.5. By Distribution Channel
23.6. Argentina Antibiotic Resistance Market Analysis
23.6.1. By Drug Class
23.6.2. By Pathogen
23.6.3. By Disease
23.6.4. By Mechanism of action
23.6.5. By Distribution Channel
23.7. U.K. Antibiotic Resistance Market Analysis
23.7.1. By Drug Class
23.7.2. By Pathogen
23.7.3. By Disease
23.7.4. By Mechanism of action
23.7.5. By Distribution Channel
23.8. Germany Antibiotic Resistance Market Analysis
23.8.1. By Drug Class
23.8.2. By Pathogen
23.8.3. By Disease
23.8.4. By Mechanism of action
23.8.5. By Distribution Channel
23.9. France Antibiotic Resistance Market Analysis
23.9.1. By Drug Class
23.9.2. By Pathogen
23.9.3. By Disease
23.9.4. By Mechanism of action
23.9.5. By Distribution Channel
23.10. Italy Antibiotic Resistance Market Analysis
23.10.1. By Drug Class
23.10.2. By Pathogen
23.10.3. By Disease
23.10.4. By Mechanism of action
23.10.5. By Distribution Channel
23.11. Spain Antibiotic Resistance Market Analysis
23.11.1. By Drug Class
23.11.2. By Pathogen
23.11.3. By Disease
23.11.4. By Distribution Channel
23.12. BENELUX Antibiotic Resistance Market Analysis
23.12.1. By Drug Class
23.12.2. By Pathogen
23.12.3. By Disease
23.12.4. By Mechanism of action
23.12.5. By Distribution Channel
23.13. Russia Antibiotic Resistance Market Analysis
23.13.1. By Drug Class
23.13.2. By Pathogen
23.13.3. By Disease
23.13.4. By Mechanism of action
23.13.5. By Distribution Channel
23.14. China Antibiotic Resistance Market Analysis
23.14.1. By Drug Class
23.14.2. By Pathogen
23.14.3. By Disease
23.14.4. By Mechanism of action
23.14.5. By Distribution Channel
23.15. Japan Antibiotic Resistance Market Analysis
23.15.1. By Drug Class
23.15.2. By Pathogen
23.15.3. By Disease
23.15.4. By Mechanism of action
23.15.5. By Distribution Channel
23.16. South Korea Antibiotic Resistance Market Analysis
23.16.1. By Drug Class
23.16.2. By Pathogen
23.16.3. By Disease
23.16.4. By Mechanism of action
23.16.5. By Distribution Channel
23.17. India Antibiotic Resistance Market Analysis
23.17.1. By Drug Class
23.17.2. By Pathogen
23.17.3. By Disease
23.17.4. By Mechanism of action
23.17.5. By Distribution Channel
23.18. Thailand Antibiotic Resistance Market Analysis
23.18.1. By Drug Class
23.18.2. By Pathogen
23.18.3. By Disease
23.18.4. By Mechanism of action
23.18.5. By Distribution Channel
23.19. Indonesia Antibiotic Resistance Market Analysis
23.19.1. By Drug Class
23.19.2. By Pathogen
23.19.3. By Disease
23.19.4. By Mechanism of action
23.19.5. By Distribution Channel
23.20. Malaysia Antibiotic Resistance Market Analysis
23.20.1. By Drug Class
23.20.2. By Pathogen
23.20.3. By Disease
23.20.4. By Mechanism of action
23.20.5. By Distribution Channel
23.21. Australia Antibiotic Resistance Market Analysis
23.21.1. By Drug Class
23.21.2. By Pathogen
23.21.3. By Disease
23.21.4. By Mechanism of action
23.21.5. By Distribution Channel
23.22. New Zealand Antibiotic Resistance Market Analysis
23.22.1. By Drug Class
23.22.2. By Pathogen
23.22.3. By Disease
23.22.4. By Mechanism of action
23.22.5. By Distribution Channel
23.23. GCC Countries Antibiotic Resistance Market Analysis
23.23.1. By Drug Class
23.23.2. By Pathogen
23.23.3. By Disease
23.23.4. By Mechanism of action
23.23.5. By Distribution Channel
23.24. Turkey Antibiotic Resistance Market Analysis
23.24.1. By Drug Class
23.24.2. By Pathogen
23.24.3. By Disease
23.24.4. By Mechanism of action
23.24.5. By Distribution Channel
23.25. North Aafrica Antibiotic Resistance Market Analysis
23.25.1. By Drug Class
23.25.2. By Pathogen
23.25.3. By Disease
23.25.4. By Mechanism of action
23.25.5. By Distribution Channel
23.26. South Africa Antibiotic Resistance Market Analysis
23.26.1. By Drug Class
23.26.2. By Pathogen
23.26.3. By Disease
23.26.4. By Mechanism of action
23.26.5. By Distribution Channel

24. Market Structure Analysis
24.1. Market Analysis by Tier of Companies 
24.2. Market Share Analysis of Top Players
24.3. Market Presence Analysis
24.3.1. Regional footprint of Players
24.3.2. Product Type foot print by Players
24.3.3. Channel Foot Print by Players

25. Competition Analysis
25.1. Competition Dashboard
25.2. Pricing Analysis by Competition
25.3. Competition Benchmarking
25.4. Competition Deep Dive 
25.4.1. Pfizer Inc
25.4.1.1. Overview
25.4.1.2. Product  Portfolio
25.4.1.3. Profitability by Market Segments (Product/Channel/Region)
25.4.1.4. Sales Footprint
25.4.1.5. Strategy Overview
25.4.1.5.1. Marketing Strategy
25.4.1.5.2. Product Strategy
25.4.1.5.3. Channel Strategy
25.4.2. GlaxoSmithKline plc 
25.4.2.1. Overview
25.4.2.2. Product  Portfolio
25.4.2.3. Profitability by Market Segments (Product/Channel/Region)
25.4.2.4. Sales Footprint
25.4.2.5. Strategy Overview
25.4.2.5.1. Marketing Strategy
25.4.2.5.2. Product Strategy
25.4.2.5.3. Channel Strategy
25.4.3. Merck & Co., Inc. 
25.4.3.1. Overview
25.4.3.2. Product  Portfolio
25.4.3.3. Profitability by Market Segments (Product/Channel/Region)
25.4.3.4. Sales Footprint
25.4.3.5. Strategy Overview
25.4.3.5.1. Marketing Strategy
25.4.3.5.2. Product Strategy
25.4.3.5.3. Channel Strategy
25.4.4. Johnsons & Johnson 
25.4.4.1. Overview
25.4.4.2. Product  Portfolio
25.4.4.3. Profitability by Market Segments (Product/Channel/Region)
25.4.4.4. Sales Footprint
25.4.4.5. Strategy Overview
25.4.4.5.1. Marketing Strategy
25.4.4.5.2. Product Strategy
25.4.4.5.3. Channel Strategy
25.4.5. Baxter Healthcare Corporation
25.4.5.1. Overview
25.4.5.2. Product  Portfolio
25.4.5.3. Profitability by Market Segments (Product/Channel/Region)
25.4.5.4. Sales Footprint
25.4.5.5. Strategy Overview
25.4.5.5.1. Marketing Strategy
25.4.5.5.2. Product Strategy
25.4.5.5.3. Channel Strategy
25.4.6. Zydus Cadila 
25.4.6.1. Overview
25.4.6.2. Product  Portfolio
25.4.6.3. Profitability by Market Segments (Product/Channel/Region)
25.4.6.4. Sales Footprint
25.4.6.5. Strategy Overview
25.4.6.5.1. Marketing Strategy
25.4.6.5.2. Product Strategy
25.4.6.5.3. Channel Strategy
25.4.7. Teva Pharmaceutical Industries Ltd. 
25.4.7.1. Overview
25.4.7.2. Product  Portfolio
25.4.7.3. Profitability by Market Segments (Product/Channel/Region)
25.4.7.4. Sales Footprint
25.4.7.5. Strategy Overview
25.4.7.5.1. Marketing Strategy
25.4.7.5.2. Product Strategy
25.4.7.5.3. Channel Strategy
25.4.8. Novartis AG 
25.4.8.1. Overview
25.4.8.2. Product  Portfolio
25.4.8.3. Profitability by Market Segments (Product/Channel/Region)
25.4.8.4. Sales Footprint
25.4.8.5. Strategy Overview
25.4.8.5.1. Marketing Strategy
25.4.8.5.2. Product Strategy
25.4.8.5.3. Channel Strategy
25.4.9. Dr. Reddy’s Laboratories Ltd.
25.4.9.1. Overview
25.4.9.2. Product  Portfolio
25.4.9.3. Profitability by Market Segments (Product/Channel/Region)
25.4.9.4. Sales Footprint
25.4.9.5. Strategy Overview
25.4.9.5.1. Marketing Strategy
25.4.9.5.2. Product Strategy
25.4.9.5.3. Channel Strategy
25.4.10. Mayne Pharma Group Limited. 
25.4.10.1. Overview
25.4.10.2. Product  Portfolio
25.4.10.3. Profitability by Market Segments (Product/Channel/Region)
25.4.10.4. Sales Footprint
25.4.10.5. Strategy Overview
25.4.10.5.1. Marketing Strategy
25.4.10.5.2. Product Strategy
25.4.10.5.3. Channel Strategy
25.4.11. Sun Pharmaceutical Industries Ltd. 
25.4.11.1. Overview
25.4.11.2. Product  Portfolio
25.4.11.3. Profitability by Market Segments (Product/Channel/Region)
25.4.11.4. Sales Footprint
25.4.11.5. Strategy Overview
25.4.11.5.1. Marketing Strategy
25.4.11.5.2. Product Strategy
25.4.11.5.3. Channel Strategy
25.4.12. Cipla Inc.
25.4.12.1. Overview
25.4.12.2. Product  Portfolio
25.4.12.3. Profitability by Market Segments (Product/Channel/Region)
25.4.12.4. Sales Footprint
25.4.12.5. Strategy Overview
25.4.12.5.1. Marketing Strategy
25.4.12.5.2. Product Strategy
25.4.12.5.3. Channel Strategy
25.4.13. Shanghai Pharmaceutical Group Co., Ltd. 
25.4.13.1. Overview
25.4.13.2. Product  Portfolio
25.4.13.3. Profitability by Market Segments (Product/Channel/Region)
25.4.13.4. Sales Footprint
25.4.13.5. Strategy Overview
25.4.13.5.1. Marketing Strategy
25.4.13.5.2. Product Strategy
25.4.13.5.3. Channel Strategy
25.4.14. Yuhan Corporation 
25.4.14.1. Overview
25.4.14.2. Product  Portfolio
25.4.14.3. Profitability by Market Segments (Product/Channel/Region)
25.4.14.4. Sales Footprint
25.4.14.5. Strategy Overview
25.4.14.5.1. Marketing Strategy
25.4.14.5.2. Product Strategy
25.4.14.5.3. Channel Strategy
25.4.15. Abbott Laboratories.
25.4.15.1. Overview
25.4.15.2. Product  Portfolio
25.4.15.3. Profitability by Market Segments (Product/Channel/Region)
25.4.15.4. Sales Footprint
25.4.15.5. Strategy Overview
25.4.15.5.1. Marketing Strategy
25.4.15.5.2. Product Strategy
25.4.15.5.3. Channel Strategy

26. Assumptions and Acronyms Used

27. Research Methodology

List of Table

Table 01: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 01: Global Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 03: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease
Table 04: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 05: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 06: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel
Table 07: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Region
Table 08: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Country
Table 09: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 10: North America Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 11: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease
Table 12: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 13: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 14: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel
Table 15: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Country
Table 16: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 17: Latin America Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 18: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease
Table 19: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 20: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 21: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel
Table 22: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Country
Table 23: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 24: Europe Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 25: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease
Table 26: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 27: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 28: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel
Table 29: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Country
Table 30: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 31: South Asia Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 32: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease
Table 33: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 34: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 35: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel
Table 36: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Country
Table 37: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 38: East Asia Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 39: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease
Table 40: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 41: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 42: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel
Table 43: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Country
Table 44: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 45: Oceania Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 46: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease
Table 47: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 48: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 49: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel
Table 50: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Country
Table 51: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 52: MEA Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 53: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease
Table 54: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 55: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 56: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel

Success Stories

Our Clients